Abdelrahman
Dolores Catania: A Reality Star’s Journey with Ozempic and Mounjaro for Weight Loss
Dolores Catania, a prominent figure from the Real Housewives of New Jersey, has made headlines for her candid admission regarding the use of weight-loss medications such as Ozempic. She is among the early celebrities to acknowledge her journey with this kind of treatment to shed pounds.
After two years of using these medications, Catania, who has successfully returned to her high school weight, stated, "I realize it’s time for me to either reduce my dosage or wean myself off the medication."
Currently, Catania is using Mounjaro, a drug similar to Ozempic that features tirzepatide as its active component. This substance imitates hormones in the brain that play a vital role in controlling appetite and the sensation of fullness.
When Catania began her medication journey, she weighed 157 pounds, initially starting with Ozempic before transitioning to Mounjaro. Throughout this period, she has achieved a weight loss of over 30 pounds.
Catania emphasizes the importance of consulting a qualified healthcare professional prior to trying such medications, stating, "It is crucial to always work with a knowledgeable doctor." She adds, "Research is essential."
For many, the desire to try these revolutionary weight loss treatments is hindered by the expense, as insurance might not cover the approximately $1,200 monthly cost. Consequently, some individuals resort to online medical consultations to obtain prescriptions.
These medications are often prepared at compounding pharmacies where pharmacists mix the necessary components. However, it is crucial to note that the FDA does not regulate this process, potentially leading to improper ingredients or dosages by careless practitioners.
Catania shared her story with Hello! magazine, explaining how Mounjaro has significantly impacted her life and that of her boyfriend, Paul Connell, who has lost 60 pounds as well. He has even stopped taking a specific blood pressure medication due to the positive changes. Although she mentions nausea as a side effect, she notes that there are pills available to manage it.
Clinical trials indicate that individuals taking Mounjaro can expect to lose between 15 to 20 percent of their body weight over approximately 72 weeks, especially when combined with a healthy diet and regular exercise.
Once a lover of carb-heavy snacks, including Doritos and onion dip, Catania has made significant dietary changes and no longer consumes these foods, as they now make her feel nauseous. Both she and Connell maintain an active lifestyle by working out three to four times a week.
Originally developed for managing type 2 diabetes, Ozempic has also been prescribed off-label to combat obesity, a trend that has taken off among celebrities. Mounjaro has similarly been recognized for its weight loss capabilities but has faced shortages as demand surged among those seeking cosmetic benefits.
Catania expressed her belief that she was among the first to speak honestly about her weight loss journey, distancing herself from vanity-driven motives, as she has genuine medical reasons for her treatment. With menopause and thyroid issues complicating her ability to lose weight, she remarked, "Even with a dedicated workout routine and a sensible diet, the weight continued to climb."
Healthcare providers often stress that while these medications are effective for weight control, they should not be viewed as a cure-all solution for obesity. Dr. Amy Lee, the Chief Medical Officer at Lindora Clinic, cautioned that stopping the medication may lead to a return of previous hunger and cravings.
A recent study involving 670 participants over 36 weeks demonstrated that individuals on tirzepatide lost an average of 20 percent of their body weight. Following this period, half of the participants maintained their dosage, while the others received a placebo. Those continuing the medication lost an average of an additional 5.5 percent of their body weight, in contrast to the placebo group, which regained 14 percent and experienced increased cholesterol and blood sugar levels.
In summary, Catania’s experience reveals the nuances of using weight loss medications, highlighting the importance of medical guidance, lifestyle adjustments, and the reality of long-term management.
